These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28933291)

  • 1. Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease.
    Lucafò M; Stankovic B; Kotur N; Di Silvestre A; Martelossi S; Ventura A; Zukic B; Pavlovic S; Decorti G
    Curr Med Chem; 2018; 25(24):2855-2871. PubMed ID: 28933291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.
    Lucafò M; Di Silvestre A; Romano M; Avian A; Antonelli R; Martelossi S; Naviglio S; Tommasini A; Stocco G; Ventura A; Decorti G; De Iudicibus S
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):87-93. PubMed ID: 28722800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.
    De Iudicibus S; Lucafò M; Martelossi S; Pierobon C; Ventura A; Decorti G
    World J Gastroenterol; 2013 Nov; 19(44):7947-54. PubMed ID: 24307788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients.
    De Iudicibus S; Lucafò M; Vitulo N; Martelossi S; Zimbello R; De Pascale F; Forcato C; Naviglio S; Di Silvestre A; Gerdol M; Stocco G; Valle G; Ventura A; Bramuzzo M; Decorti G
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
    De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
    World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of genetic factors on response to glucocorticoids therapy in IBD.
    Gabryel M; Skrzypczak-Zielinska M; Kucharski MA; Slomski R; Dobrowolska A
    Scand J Gastroenterol; 2016; 51(6):654-65. PubMed ID: 26776488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice.
    Bruscoli S; Febo M; Riccardi C; Migliorati G
    Front Immunol; 2021; 12():691480. PubMed ID: 34149734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid sensitivity in inflammatory bowel disease.
    Sidoroff M; Kolho KL
    Ann Med; 2012 Sep; 44(6):578-87. PubMed ID: 21992564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory bowel disease--the role and issue of glucocorticoid].
    Ashida T
    Nihon Rinsho; 2008 Jan; 66(1):137-41. PubMed ID: 18186257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.
    Cuzzoni E; De Iudicibus S; Franca R; Stocco G; Lucafò M; Pelin M; Favretto D; Pasini A; Montini G; Decorti G
    Pharmacogenomics; 2015; 16(14):1631-48. PubMed ID: 26419298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases.
    De Iudicibus S; Stocco G; Martelossi S; Londero M; Ebner E; Pontillo A; Lionetti P; Barabino A; Bartoli F; Ventura A; Decorti G
    J Clin Gastroenterol; 2011 Jan; 45(1):e1-7. PubMed ID: 20697295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of microRNAs on glucocorticoid responsiveness.
    Wang H; Gou X; Jiang T; Ouyang J
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1005-1011. PubMed ID: 28286901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNAs in glucocorticoid action.
    Clayton SA; Jones SW; Kurowska-Stolarska M; Clark AR
    J Biol Chem; 2018 Feb; 293(6):1865-1874. PubMed ID: 29301941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD.
    Hausmann M; Herfarth H; Schölmerich J; Rogler G
    Gut; 2007 Sep; 56(9):1328-9. PubMed ID: 17698877
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders.
    Xicota L; De Toma I; Maffioletti E; Pisanu C; Squassina A; Baune BT; Potier MC; Stacey D; Dierssen M;
    Eur Neuropsychopharmacol; 2022 Jan; 54():41-53. PubMed ID: 34743061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.
    Reuter KC; Grunwitz CR; Kaminski BM; Steinhilber D; Radeke HH; Stein J
    J Pharmacol Exp Ther; 2012 Apr; 341(1):68-80. PubMed ID: 22235147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression analysis among microRNAs, long non-coding RNAs, and messenger RNAs to understand the pathogenesis and progression of diabetic kidney disease at the genetic level.
    Zhang L; Li R; He J; Yang Q; Wu Y; Huang J; Wu B
    Methods; 2017 Jul; 124():46-56. PubMed ID: 28577935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids in pediatric inflammatory bowel disease.
    Sidoroff M; Kolho KL
    Scand J Gastroenterol; 2012 Jul; 47(7):745-50. PubMed ID: 22507033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.